Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Bushra Q. AlOtaibi"'
Autor:
Yazed AlRuthia, Bushra Q. AlOtaibi, Reem M. AlOtaibi, Najla Q. AlOtaibi, Miteb Alanazi, Ghadah Asaad Assiri
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 1, Pp 119-124 (2023)
Background: Rivaroxaban is a novel oral anticoagulant (NOAC) that is commonly used for stroke prevention among patients with atrial fibrillation (AF). However, its cost effectiveness in reducing the risk of hospitalization and mortality in comparison
Externí odkaz:
https://doaj.org/article/f6fa0820eb3944b187ca3a58bfc05833
